2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato(CAS: 1367369-79-6)
![2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato](https://cnstatic.chemtradehub.com/structs/136/1367369-79-6-53e2.webp)
CAS号
相关产品
其他供应商提供的 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato
基本信息
分子式
C12H15N5O3
分子量
277.28 g/mol
Physical Properties
沸点
661.4±65.0 °C(Predicted)
密度
1.81±0.1 g/cm3(Predicted)
化学标识符
SMILES
C=C1C(CC(C1CO)O)n2cnc3c2[nH]c(nc3=O)N
InChIKey
QDGZDCVAUDNJFG-UHFFFAOYSA-N
数据库引用
MDL号
MFCD31562807
常见问题
恩替卡韦杂质SSR需要遵循《危险品分类全球统一制度》(GHS)、《化学品注册、评估、授权和限制》(REACH)法规以及《食品和药物管理局》(FDA)和《环境保护局》(EPA)的相关规定。这些法规旨在确保化学品的安全使用、储存和处置。
在合成过程中,可以使用类似物或异构体作为替代品,例如使用2-Amino-9-(4-hydroxy-3-(hydroxymethyl)-2-methylcyclopentyl)-1,9-dihydro-6H-purin-6-one的类似化合物,如2-Amino-9-(4-hydroxy-3-(hydroxymethyl)cyclopentyl)-1,9-dihydro-6H-purin-6-one,以减少杂质SSR的产生。
恩替卡韦杂质SSR的研究趋势主要集中在降低杂质水平以提高药品纯度和疗效。随着对药品安全性和有效性的日益重视,未来的研究将更侧重于开发更高效的分离技术,减少杂质SSR的产生。
含有恩替卡韦杂质SSR的废料应先进行分离处理以减少毒性,然后通过焚烧或送至专业废弃物处理设施进行处理。处理过程中需要严格遵守GHS和REACH等法规要求,确保安全环保。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![2-Amino-9-[(1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one](https://cnstatic.chemtradehub.com/structs/136/1367369-76-3-3b30.webp)
![(2'S,3S,5'S,6'R,8'R,11'S)-4'-Methyl-2'-vinylspiro[indole-3,7'-[9]oxa[4]azatetracyclo[6.3.1.0~2,6~.0~5,11~]dodecan]-2(1H)-one](https://cnstatic.chemtradehub.com/structs/509/509-15-9-847b.webp)

![7-Bromo-6-chloro-3-{3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl}-4(3H)-quinazolinone](https://cnstatic.chemtradehub.com/structs/558/55837-20-2-0d73.webp)
![(3aR,7S,16aS)-2,7-Dihydroxy-3-[(2S)-1-hydroxy-2-propanyl]-6,10,14,16a-tetramethyl-4,7,8,9,12,13,16,16a-octahydrocyclopenta[15]annulen-1(3aH)-one](https://cnstatic.chemtradehub.com/structs/146/146436-22-8-697e.webp)
![2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one](https://cnstatic.chemtradehub.com/structs/142/142217-69-4-3af1.webp)

![2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one](https://cnstatic.chemtradehub.com/structs/136/1367369-77-4-143c.webp)
![2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato — 湖北扬信医药科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)
![2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato — 深圳振强生物技术有限公司](https://cnstatic.chemtradehub.com/suppliers/67cec9142b2de6e8e95a51e7/67cec9142b2de6e8e95a51e7-logo.webp)
